VVOS
Vivos·NASDAQ
--
--(--)
--
--(--)
VVOS Filings
Filing Date
Form Description
Form Type
2026-02-06
Form 8-K - Current report
Key Events
2026-02-06 · Key Events
Form 8-K - Current report
2026-01-20
Form 8-K - Current report
Key Events
2026-01-20 · Key Events
Form 8-K - Current report
2026-01-16
Form 8-K - Current report
Key Events
2026-01-16 · Key Events
Form 8-K - Current report
2026-01-14
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-14 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-08
Form EFFECT - Notice of Effectiveness
2026-01-08 ·
Form EFFECT - Notice of Effectiveness
2026-01-02
Form POS AM - Post-Effective amendments for registration statement
2026-01-02 ·
Form POS AM - Post-Effective amendments for registration statement
2025-12-17
Form 8-K - Current report
Key Events
2025-12-17 · Key Events
Form 8-K - Current report
2025-12-05
Form 8-K - Current report
Key Events
2025-12-05 · Key Events
Form 8-K - Current report
2025-11-19
Vivos Therapeutics, Inc. (VVOS) Q3 2025 Earnings Call Transcript
Earnings Call
2025-11-19 · Earnings Call
Vivos Therapeutics, Inc. (VVOS) Q3 2025 Earnings Call Transcript
2025-11-19
Form 8-K - Current report
Key Events
2025-11-19 · Key Events
Form 8-K - Current report
